MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Zoiray Technologies Inc., Boston
Zoiray makes a simple-to-use tabletop units that scan binding interactions in real time, label-free.
Officers
David Bergstein, President & CEO
Linda Smith, VP of Marketing
Directors
David Bergstein, M. Selim Unlu, Charles DeLisi
Product
Zoíray has sold three prototype instruments in the life science research market. The instruments are simple-to-use tabletop units that scan binding interactions in real time, label-free.
A simpler, next-generation instrument is in development and will be supplied with slides featuring Zoiray’s proprietary high-performance surface chemistry. The non-conforming 3D surface optimizes probe activity and resists non-specific binding for clean repeatable results. Ultimately, Zoiray will sell diagnostic chips for clinical in vitro monitoring of disease.